Systemic sclerosis and pregnancy
Keywords:
systemic sclerosis, pregnancy, fertility, pre-term birth small full-term infantsAbstract
Systemic sclerosis is a not common disease, which is frequent in women with ages from 30 to 50 years old, generally after reproductive life, however, is not an exception that pregnancy will outcome because there is not any affection of fertility ability among this patients. It is well known that in those patients there is a higher incidence of pre-term birth and small full-term infants, without significant ratios of maternal complications. Clinical activity of SSc does not change during pregnancy according to most of the authors, although in patients which have pre-existence of nephropathy is common to develop toxemia and renal crisis could appear early. Respect to SSc treatment during pregnancy it must be personalized and should be used less drugs as possible. It is recommended that these patients must be treated by interdisciplinary equipment with rheumatologist included in order to reduce maternal-fetal and neonatal complications.Downloads
References
Valentini G, Medsger TA, Silman AJ, Bombardieri S. The assessment of the patient with systemic sclerosis. Clin Exp Rheumatol. 2003;2(6):370-6.
Andreu JL, Sanz J, Mulero J. Esclerosis sistémica (esclerodermia) Reumatología Clínica. 2000; 8(30):1543-52.
Bustabad S, Rodriguez B, Bethencourt JJ .Preesclerodermia .Semin Fund Esp Reumatol. 2011;12(4):123-7.
Silman AJ, Hochberg MC Occupational and environmental influences on scleroderma. Rheum Dis Clin N Am. 1996;22:737-49.
Roa J. Avances en la Clasificación, Inmunopatogenia y Tratamiento de la Esclerodermia. Reumatología.. 2005;21(1):27-32.
Black C, Denton C, Gay S, Huber L and Seybold J .Advances in systemic sclerosis and related fibrotic and vascular conditions. Arthritis Res Ther. 2007;9 Suppl 2:S47-6.
Vera-Lastra OL .Esclerosis sistémica y tracto gastrointestinal. Abordaje diagnóstico y terapéutico. Reumatología Clínica. 2006;2(3):24-30.
Strollo D; Goldin J .Imaging Lung Disease in Systemic Sclerosis.Curr Rheumatol Rep. 2010;12:156-61.
Jara LJ .Barrera A: Afección Renal en la Esclerosis Sistémica. Reumatología Clínica. 2006;2(3):20-23.
Mecacci F, Pieralli A, Paidas MJ. El impacto de los trastornos autoinmunes y los resultados adversos del embarazo. Semin Perinatol. 2007;31(4):223-6.
Fautrel B, Benhamou M. Enfermedades inflamatorias crónicas y la reproducción .Gynecol Obstet Fértil. 2007;35(9):848-52.
Arlet CM, Smith JB, Jiménez SA. Identification of fetal DNA and cells in skin lesion from women with systemic sclerosis. N Eng J Med. 1998;338:1186-91.
Christmann de Souza et al: Avaliacao dos factores Reproductivos em 117 pacientes.com Esclerose Sistemica Forma Limitada e 72 pacientes com Artrite Reumatoide. Rev. Bras. Reumatol. 2005;45(3):114-8.
Rak JM, Pagni PP, Tiev K, Allanore Y, Farge D, Harlé JR et al .Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset. Rheumatology (Oxford). 2009;48(4):363-6.
Burastero SE, Galbiati S, Vassallo A, Sabbadini MG, Bellone M, Marchionni L, et al.Cellular microchimerism as a lifelong physiologic status in parous women: an immunologic basis for its amplification in patients with systemic sclerosis. Arthritis Rheum. 2003;48(4):1109-16.
Artlett CM, Rasheed M, Russo-Stieglitz KE, Sawaya HH, Jimenez SA .Influence of prior pregnancies on disease course and cause of death in systemic sclerosis. Ann Rheum Dis. 2002;61(4):346-50.
Scaletti C, Vultaggio A, Bonifacio S,et al . Th2-oriented profile of male offspring T cell present in women with Systemic Sclerosis and reactive Major Histocompatibility Complets Antigens . Arthritis Rheum. 2002;46:445-50.
Steen VD, Brodeur M, Conte C. Prospective Pregnancy (PG) study in women with systemic sclerosis (SSc). Arthritis Rheum 1999;39:5151-63.
Steen VD. Pregnancy in scleroderma. Rheum Dis Clin North Am. 2007;33(2):345-58.
Toro CE, Quintana MA, Escobar MF, Cañas CA, Iglesias A, Restrepo JF. Enfermedad reumatológica y embarazo. Rev. Colombiana de Reumatologia. 2007;14 (1):54-64.
Buitron R, Zaruma F, Rivas R, Romero R: Esclerosis sistémica (esclerodermia) y embarazo. Reporte de un caso. Revista Médica del Hospital General de México. 2004;1(6):34-52.
Chakravarty E, Khanna D, and Chung L. Pregnancy Outcomes in Systemic Sclerosis, Primary Pulmonary Hypertension, and Sickle Cell Disease. Obstetrics & Gynecology. 2008;111:927-34.
Steen et al. Prospective Pregnancy (PG) study in women with systemic sclerosis. Obstet Gynecol. 1999;3(7):31-9.
Virginia DS, Thomas AM. Fertility and pregnancy outcome in women with systemic sclerosis. Am Col Rheumatol. 1999;42(4):763-68.
Chung L .Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease. Lupus 2006;15(9):595-9.
Ramírez E, Berrocal A , Calvo A. Esclerosis sistémica progresiva y embarazo: Reporte de 3 casos . Boletín de la Sociedad Peruana de Medicina Interna. 1999; 12 (2): 23-28.
Miniati I, Guiducci S, Mecacci F, Mello G, Matucci-Cerinic M. Pregnancy in systemic sclerosis. Rheumatology (Oxford). 2008;47 Suppl 3:S6-8.
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature: